Biological reactive intermediates that mediate dacarbazine cytotoxicityPOURAHMAD, Jalal; AMIRMOSTOFIAN, Marzieh; KOBARFARD, Farzad et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 1, pp 89-96, issn 0344-5704, 8 p.Article

Fotosensibilidad por dacarbacina (DTIC) = Dacarbazine [DTIC]-induced photosensitivity reactionFERNANDEZ DE VILLATA, Maria José G; RUIZ-GENAO, Diana; SANCHEZ-PEREZ, Javier et al.Actas dermo-sifiliográficas (Ed. impresa). 2003, Vol 94, Num 8, pp 549-551, issn 0001-7310, 3 p.Article

Farnesyl thiosalicylic acid chemosensitizes human melanoma in vivoHALASCHEK-WIENER, Julius; KLOOG, Yoel; WACHECK, Volker et al.Journal of investigative dermatology. 2003, Vol 120, Num 1, pp 109-115, issn 0022-202X, 7 p.Article

Effects of cisplatin, bleomycin and DTIC on immune function in vitro and in vivoKLEINERMAN, E. S; ZWELLING, L. A.Clinics in immunology and allergy. 1984, Vol 4, Num 2, pp 279-294, issn 0260-4639Article

Interaction of Dacarbazine and Imexon, In Vitro and In Vivo, in Human A375 Melanoma CellsSAMULITIS, Betty K; DORR, Robert T; CHOW, H.-H. Sherry et al.Anticancer research. 2011, Vol 31, Num 9, pp 2781-2785, issn 0250-7005, 5 p.Article

Mechanism of UVA-dependent DNA Damage Induced by An Antitumor Drug Dacarbazine in Relation to its PhotogenotoxicityIWAMOTO, Takuya; HIRAKU, Yusuke; OKUDA, Masahiro et al.Pharmaceutical research. 2008, Vol 25, Num 3, pp 598-604, issn 0724-8741, 7 p.Article

Re-evaluating the role of dacarbazine in metastatic melanoma : What have we learned in 30 years?EGGERMONT, Alexander M. M; KIRKWOOD, John M.European journal of cancer (1990). 2004, Vol 40, Num 12, pp 1825-1836, issn 0959-8049, 12 p.Article

Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosisSANADA, Masayuki; HIDAKA, Masumi; TAKAGI, Yasumitsu et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 12, pp 2657-2663, issn 0143-3334, 7 p.Article

Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and AntiangiogenicsSTACCHIOTTI, S; TORTORETO, M; GRONCHI, A et al.Clinical cancer research (Print). 2013, Vol 19, Num 18, pp 5192-5201, issn 1078-0432, 10 p.Article

Dacarbazine Promotes Stromal Remodeling and Lymphocyte Infiltration in Cutaneous Melanoma LesionsNARDIN, Alessandra; WONG, Wing-Cheong; PREVOST-BLONDEL, Armelle et al.Journal of investigative dermatology. 2011, Vol 131, Num 9, pp 1896-1905, issn 0022-202X, 10 p.Article

Dacarbazine : Déticène® = Dacarbazine : Deticene®QUEREUX, G; BROCARD, A; DRENO, B et al.Annales de dermatologie et de vénéréologie. 2007, Vol 134, Num 12, pp 1001-1003, issn 0151-9638, 3 p.Article

Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivoLEV, Dina Chelouche; ONN, Amir; MELINKOVA, Vladislava O et al.Journal of clinical oncology. 2004, Vol 22, Num 11, pp 2092-2100, issn 0732-183X, 9 p.Article

Effect of DNA repair host factors on temozolomide or dacarbazine melanoma treatment in CaucasiansBOECKMANN, Lars; SCHIRMER, Markus; SCHOEN, Michael P et al.Pharmacogenetics and genomics (Print). 2009, Vol 19, Num 10, pp 760-769, issn 1744-6872, 10 p.Article

Combined Treatment With Pegylated Interferon-α-2a and Dacarbazine in Patients With Advanced Metastatic Melanoma : A Phase 2 StudyHAUSCHILD, Axel; DUMMER, Reinhard; UGUREL, Selma et al.Cancer. 2008, Vol 113, Num 6, pp 1404-1411, issn 0008-543X, 8 p.Article

TREATMENT OF ADVANCED MALIGNANT HEMANGIOPERICYTOMA WITH COMBINATION ADRIAMYCIN AND DTIC: A REPORT OF FOUR CASES = TRAITEMENT DES HEMANGIOPERICYTOMES MALINS AVANCES PAR ASSOCIATION D'ADRIAMYCINE ET DE DTIC: A PROPOS DE QUATRE CASBEADLE GF; HILLCOAT BL.1983; JOURNAL OF SURGICAL ONCOLOGY; ISSN 0022-4790; USA; DA. 1983; VOL. 22; NO 3; PP. 167-170; ABS. ENG; BIBL. 19 REF.Article

PHOTOSENSITIVITY REACTION FOLLOWING DTIC ADMINISTRATION: REPORT OF TWO CASESBECK TM; HART NE; SMITH CE et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 4-5; PP. 725-726; BIBL. 5 REF.Article

EFFECTIVE TREATMENT OF KAPOSI'S SARCOMA WITH 5-(3,3-DIMETHYL-1-TRIAZENO) IMIDAZOLE-4-CARBOXAMIDE (NSC-45388)VOGEL CL; PRIMACK A; OWOR R et al.1973; CANCER CHEMOTHERAPY REP., I; U.S.A.; DA. 1973; VOL. 57; NO 1; PP. 65-71; BIBL. 12REF.Serial Issue

A Phase 1-2 Study of Imexon Plus Dacarbazine in Patients With Unresectable Metastatic MelanomaWEBER, Jeffrey S; SAMLOWSKI, Wolfram E; GONZALEZ, Rene et al.Cancer. 2010, Vol 116, Num 15, pp 3683-3691, issn 0008-543X, 9 p.Article

Phase I―II study of plitidepsin and dacarbazine as first-line therapy for advanced melanomaPLUMMER, R; LORIGAN, P; KAHATT, C et al.British journal of cancer. 2013, Vol 109, Num 6, pp 1451-1459, issn 0007-0920, 9 p.Article

OBSERVATIONS ON THE "IN VITRO" OXIDATIVE N-DEMETHYLATION OF 4-(3,3-DIMETHYL-L-TRIAZENO)-IMIDAZOLE-5-CARBOXAMIDE (DIC, NSC 45388)GIRALDI T; NISI C; SAVA G et al.1976; PHARMACOL. RES. COMMUNIC.; G.B.; DA. 1976; VOL. 8; NO 1; PP. 25-29; BIBL. 14 REF.Article

CHEMOTHERAPY OF SARCOMAS WITH A COMBINATION OF ADRIAMYCIN AND DIMETHYL TRIAZENO IMIDAZOLE CARBOXAMIDEGOTTLIEB JA; BAKER LH; QUAGLIANA JM et al.1972; CANCER; U.S.A.; DA. 1972; VOL. 30; NO 6; PP. 1632-1638; BIBL. 29 REF.Serial Issue

5-(3,3-DIMETHYL-1-TRIAZENO) IMIDAZOLE-4-CARBOXAMIDE (NSC-45388) IN THE TREATMENT OF SOLID TUMORS IN CHILDRENFINKLESTEIN JZ; ALBO V; ERTEL I et al.1975; CANCER CHEMOTHERAPY REP.; U.S.A.; DA. 1975; VOL. 59; NO 2; PP. 351-357; BIBL. 8 REF.Article

DTIC (NSC-45388) TOXICITYMOORE GE; MEISELBAUGH D.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 3; PP. 219Article

Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)PATEL, Poulam M; SUCIU, Stefan; BECKER, Juergen et al.European journal of cancer (1990). 2011, Vol 47, Num 10, pp 1476-1483, issn 0959-8049, 8 p.Article

LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)AGARWALA, Sanjiv S; KEILHOLZ, Ulrich; GILLES, Erard et al.European journal of cancer (1990). 2009, Vol 45, Num 10, pp 1807-1814, issn 0959-8049, 8 p.Article